Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Presentations by members of HERC at the iHEA World Congress on 10-13 July in Toronto, Canada.

-----------

'Micro-costing, Gross-costing or HRGs: Does the choice of cost approach matter in clinical trials?' Authors: Giselle Abangma, Helen Dakin, Sarah Wordsworth and the IVAN trial group.

Presented by: Giselle Abangma

-----------

'The effect of diabetes related complications on marginal utility: Estimating the bias due to unobservable heterogeneity using the UKPDS' Authors: Maria Alva, Alastair Gray , Borislava Mihaylova and Phillip Clarke

Presented by: Maria L. Alva

-----------

'Economic evaluation of factorial randomised controlled trials: Why the method of analysis matters' Authors: Helen Dakin and Alastair Gray

Presented by: Helen Dakin

-----------

'Ethnic differences in the income/child health gradient: the role of antenatal care and maternal health behaviours' Authors: Mara Violato, Stavros Petrou, Ron Gray and Maggie Redshaw

Presented by: Mara Violato

-----------

'Evaluating the impact of a social experiment on improving financial risk protection for chronic patients in rural China' 

Presented by: Winnie Yip et al

-----------

'Impacts of Capitation and Pay-for-performance on Health Expenditure and Vertical Integration: A social experiment in rural China' 

Presented by: Winnie Yip et al

-----------

'Evidence Synthesis Frameworks to inform healthcare decision making: A practical application to prostate cancer screening' 

Presented by: Jose Leal et al

-----------

'Parametric methods for modelling and extrapolation in clinical trials: Implications for economic evaluation and ways forward' 

Presented by: Borislava Mihaylova et al

-----------

UK research expenditure on chronic diseases: Is the level of spending related to the burden of disease? 

Poster Presentation by: Ramon Luengo-Fernandez et al